Paxlovid safe for pregnant COVID-19 patients, study finds

The two drugs used in COVID-19 antiviral Paxlovid are safe and effective among pregnant patients — who are at high risk for complications if they contract COVID-19 — researchers from Baltimore-based Johns Hopkins University found. 

Of the 47 pregnant study participants, most were vaccinated and only two stopped taking nirmatrelvir and ritonavir because of side effects, according to a study published Nov. 29 in JAMA

There were no reported complications with the drug combination, but there was a higher prevalence of cesarean section deliveries than expected. After taking the two drugs, 12 study participants had C-sections, nine of which were planned. 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars

/30116360/HR_Homepage_300x250-1

/30116360/HR_Homepage_300x250-2